When Drug Marketing Masquerades as Clinical Trials
Neurology® Podcast
Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care. Read the related article on . Disclosures can be found at .
info_outline
Neurology® at 75: The Evolution of the Neurology Journal
Neurology® Podcast
To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal’s history, its evolution, and what lies ahead for the future of Neurology®. Read more about the first . Disclosures can be found at .
info_outline
Navigating the Transition From Pediatric to Adult Epilepsy Care
Neurology® Podcast
Dr. Dara Albert talks with Dr. Scott Perry about improving the transition from pediatric to adult epilepsy care. Read the related article in Disclosures can be found at .
info_outline
Communication About Uncertainty During PD Diagnostic Consultations
Neurology® Podcast
Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding. Read the related article in . Disclosures can be found at .
info_outline
July 2026 Recall: Updates in Epilepsy
Neurology® Podcast
The July 2026 Recall features four previously posted episodes related to updates in epilepsy. The episode opens with Dr. Rosemary Dray-Spira discussing trends in prenatal exposure to antiseizure medications over the past decade. The episode continues with Dr. Page Pennell discussing antiseizure medication management during pregnancy and postpartum. The episode then transitions into a conversation with Dr. Matthew Ryan Woodward on the complexities of status epilepticus, focusing on its definitions, the transition to refractory and super-refractory states, and the implications for treatment. In...
info_outline
Comparing Sensitivity of Nerve Biopsy, Skin Biopsy, and Fat Aspirate in ATTRv-PN
Neurology® Podcast
Dr. Katie Krulisky talks with Dr. Marcus Pinto about the diagnosis and management of hereditary ATTR amyloidosis. Read the related article in . Disclosures can be found at .
info_outline
2026 European Stroke Organization Conference
Neurology® Podcast
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent research presented at the 2026 European Stroke Organization Conference. Read more about . Read more about the . Disclosures can be found at .
info_outline
Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
Neurology® Podcast
Dr. Shuvro Roy talks with Dr. Michael Levy about satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. Read more about . Disclosures can be found at .
info_outline
The Role of Social Media in Neurology Trainees' Professional Identity Formation
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Gabriela Figueiredo Pucci about how participation in a social media community influenced PIF and career development among neurology trainees. Read the related article in . Disclosures can be found at .
info_outline
Neurology Wait Times After Primary Care or Emergency Department Visits
Neurology® Podcast
Dr. Stacey Clardy talks with Dr. John Ney about wait times for new neurology office visits among commercially insured persons in the United States. Read the related article in . Disclosures can be found at .
info_outlineThe November 2023 replay of past episodes showcases five interviews on topics in stroke. The episode begins with an interview with Dr. Imogene Scott on prehospital telestroke vs paramedic scores to accurately identify stroke reperfusion candidates. The episode continues with an interview with Dr. David Seiffge on the use of oral anticoagulants on ischemic stroke. The next interview is with Dr. Alejandro Rabinstein and Hassan Kobeissi on comparing outcomes between CTP and NCCT for endovascular therapy selection in the late therapeutic window. The fourth interview is with Dr. Thanh Nguyen discussing whether dual antiplatelet therapy is non-inferior to intravenous thrombolysis among patients with minor non-disabling acute ischemic stroke. The November Recall concludes with Dr. Seemant Chaturvedi discussing this year's European Stroke Organization Conference and pivotal trials that were presented during the conference.
Related Podcast Links:
Pre-Hospital Evaluation of Acute Stroke: EMS vs Telemed: https://directory.libsyn.com/episode/index/id/24928863
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants: https://directory.libsyn.com/episode/index/id/25736865
CT Perfusion vs CT for Late Window Stroke Thrombectomy: https://directory.libsyn.com/episode/index/id/26673237
Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke: https://directory.libsyn.com/episode/index/id/27455412
Pivotal Stroke Trials Presented at this Year’s ESOC: https://directory.libsyn.com/episode/index/id/27279144
Related Article Links:
Prehospital Telestroke vs Paramedic Scores to Accurately Identify Stroke Reperfusion Candidates: A Cluster Randomized Controlled Trial: https://n.neurology.org/content/99/19/e2125
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants: https://jamanetwork.com/journals/jamaneurology/fullarticle/2799622
CT Perfusion vs Noncontrast CT for Late Window Stroke Thrombectomy: A Systematic Review and Meta-analysis: https://n.neurology.org/content/100/22/e2304
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial: https://jamanetwork.com/journals/jama/article-abstract/2806532
ESOC Plenary: https://2023.eso-conference.org/programme/plenary-highlights/
Disclosures can be found at Neurology.org